Patient Acquisition for Fertility Clinics
Corridor-specific campaigns and patient nurturing for IVF and reproductive medicine.
IVF and reproductive medicine is one of the clearest cases for a dedicated patient acquisition platform: the procedure is high-value, the decision takes weeks of research, and the patient is often comparing clinics across two or three countries before they ever pick up a phone. Generic international marketing does not work for this specialty. Corridor-specific campaigns and patient nurturing do.
Fertility patients research longer, involve family in the decision more than almost any other specialty, and carry specific anxieties that a generic medical-tourism funnel does not address: donor and treatment legality in their home country, travel timing around a treatment cycle, and price transparency on a package that can shift based on individual protocol. A platform built for this specialty has to account for all three before a single ad runs.
Treatment legality and availability vary sharply by home country. This is not a footnote, it is often the actual reason a patient is searching abroad at all, and campaigns and nurturing content need to reflect it accurately rather than treating every corridor as price-driven.
Setup runs two weeks: corridor and treatment-type mapping specific to your clinic’s protocols, campaign build, and a regulatory pass on every piece of patient-facing content given how closely fertility advertising is scrutinized. Campaigns go live in weeks three and four, with first enquiries typically arriving within one to two weeks of launch. From month two, corridor mix and messaging are tuned against actual conversion data rather than assumptions made at setup.
Will donor and treatment legality differences confuse the campaigns? No, they shape them. A patient searching because a treatment or donor program isn’t legally available at home is a different lead than a price-driven one, and needs different messaging and follow-up. Corridor mapping accounts for this before any campaign launches, not after.
Can you promise a success rate to attract patients? No, and we wouldn’t advise it even where it’s technically permitted. Fertility carries some of the tightest outcome-advertising scrutiny of any specialty. Everything patient-facing is framed as education: what a protocol involves, what to expect logistically, what to ask before choosing a clinic.
Our patients take weeks and involve family in the decision. Does that work against a paid campaign? It’s the reason a campaign alone doesn’t work and sustained nurturing does. Family involvement means more research touchpoints, not less interest. The follow-up cadence is built around that pattern rather than treating a slow decision as a lost lead.
Fertility patients share more sensitive documentation than almost any other specialty: prior treatment reports, hormone panels, scan results, sometimes a partner’s results too. Every document or image a patient sends is read and stripped of identifying information locally, on infrastructure we control, before any part of it is analyzed. Nothing about a patient’s identity or their medical history leaves the server unredacted. This isn’t a policy commitment layered on top; it’s how the pipeline is built.
Fertility carries some of the strictest outcome-advertising scrutiny of any specialty. We do not make success-rate or outcome claims, patient-facing content is framed as education (what a treatment involves, what to expect logistically, what to ask before choosing a clinic), consistent with regulatory guidance in the corridors we operate in.
Fertility clinics and reproductive medicine centers where international or high-value domestic self-pay patients are a meaningful part of the pipeline, and where nobody internally has the bandwidth to run financial qualification and multi-week, multilingual follow-up alongside the marketing itself.
